Exploring formulation options for extended release minitablets.
Saved in:
| Title: | Exploring formulation options for extended release minitablets. |
|---|---|
| Authors: | Bochmann E; Abbvie Deutschland GmbH & Co. KG, Drug Product Design & Development, Ludwigshafen, Germany. Electronic address: esther.bochmann@abbvie.com., Eugenia-Ilieva E; Abbvie Deutschland GmbH & Co. KG, Small Molecule Analytical R&D, Ludwigshafen, Germany., Heil S; Abbvie Deutschland GmbH & Co. KG, Small Molecule Analytical R&D, Ludwigshafen, Germany., Katz JM; Abbvie Inc., Small Molecule Drug Product Development, Lake County, USA., Koziolek M; Abbvie Deutschland GmbH & Co. KG, Drug Product Design & Development, Ludwigshafen, Germany., Marmol AL; Abbvie Deutschland GmbH & Co. KG, Drug Product Design & Development, Ludwigshafen, Germany., Sanzgiri Y; Abbvie Inc., CMC Strategy, Lake County, USA., Westedt U; Abbvie Deutschland GmbH & Co. KG, Drug Product Design & Development, Ludwigshafen, Germany. |
| Source: | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2026 Jun 09, pp. 115145. Date of Electronic Publication: 2026 Jun 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3441 (Electronic) Linking ISSN: 09396411 NLM ISO Abbreviation: Eur J Pharm Biopharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
